BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 2004;20 Suppl 4:50-3. [PMID: 15352894 DOI: 10.1111/j.1365-2036.2004.02055.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li JX, Chiang CC, Chen SN, Lin JM, Tsai YY. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2022;19. [PMID: 36497759 DOI: 10.3390/ijerph192315683] [Reference Citation Analysis]
2 D’angelo T, Mazziotti S, Blandino A, Cicero G. Extraintestinal Complications in Crohn’s Disease: MR-Enterography Findings. MR Enterography 2022. [DOI: 10.1007/978-3-031-11930-9_6] [Reference Citation Analysis]
3 Koumaki D, Machaira A, Katoulis AC, Bitados P, Orfanoudaki E, Foteinogiannopoulou K, Stefanidou M, Krasagakis K, Koutroubakis IE. Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort. Eur J Gastroenterol Hepatol 2021;33:1387-93. [PMID: 33470697 DOI: 10.1097/MEG.0000000000002053] [Reference Citation Analysis]
4 King D, Chandan JS, Thomas T, Nirantharakumar K, Reulen RC, Adderley NJ, Trudgill N. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1731-9. [PMID: 34669933 DOI: 10.1093/ibd/izaa344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ahmed M. Extra-Intestinal Features of Crohn’s Disease. Crohn’s Disease Recent Advances 2021. [DOI: 10.5772/intechopen.100164] [Reference Citation Analysis]
6 Jo UH, Lee JY, Lee H, Kim DY, Kang S, Koh SJ, Park H. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population. J Dermatol 2021;48:431-8. [PMID: 33608949 DOI: 10.1111/1346-8138.15676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Buck M, Dumic I, McDermott W, Nordstrom C, Dawan S, Virata A, Martin S, Hudson A, Milovanovic T, Nordin T. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report. BMC Gastroenterol 2020;20:240. [PMID: 32727390 DOI: 10.1186/s12876-020-01371-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Sharif M, Saddique MU, Zahid M, Khan D, Bashir T, Murshed K. Oropharyngeal Candidiasis as a Presenting Symptom of Crohn's Disease. Case Rep Gastroenterol 2020;14:178-85. [PMID: 32399001 DOI: 10.1159/000506931] [Reference Citation Analysis]
9 Lu PD, Zhao YH. Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 2020;15:15. [PMID: 32063999 DOI: 10.1186/s13020-020-0296-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
10 Atay K, Eyvazov H, Bozcan S, Eşkazan T, Demir N, Hatemi İ, Erzin Y, Çelik AF. The effect of concomitant ankylosing spondylitis on long-term outcome of patients with inflammatory bowel disease. Turk J Gastroenterol 2019;30:599-604. [PMID: 31290746 DOI: 10.5152/tjg.2019.17291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Rusoniene S, Urbonas V, Avcin T. Extraintestinal Manifestations of Inflammatory Bowel Disease. Periodic and Non-Periodic Fevers 2020. [DOI: 10.1007/978-3-030-19055-2_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Richter L, Rappersberger K. Hauterscheinungen bei CED. Pädiatrie 2019;31:28-33. [DOI: 10.1007/s15014-019-1624-6] [Reference Citation Analysis]
13 Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. PLoS One 2019;14:e0210436. [PMID: 30682031 DOI: 10.1371/journal.pone.0210436] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
14 Becker-Weidman D, Mhuircheartaigh JN, Mortele KJ. The skinny on skin: MRI features of cutaneous and subcutaneous lesions detected on body MRI studies. Abdom Radiol (NY) 2018;43:2823-50. [PMID: 29525881 DOI: 10.1007/s00261-018-1543-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Yang BR, Choi NK, Kim MS, Chun J, Joo SH, Kim H, Lee J. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLoS One. 2018;13:e0200363. [PMID: 29990326 DOI: 10.1371/journal.pone.0200363] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
16 Vide J, Osório F, Costa-Silva M, Lopes S, Azevedo F, Camila Dias C, Magina S, Magro F. Cutaneous Morbidity Among Inflammatory Bowel Disease Patients: A Cohort Study. J Crohns Colitis 2018;12:442-51. [PMID: 29300856 DOI: 10.1093/ecco-jcc/jjx178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
17 Alcalá R, González-enseñat MA, Vicente A. Manifestaciones mucocutáneas de la enfermedad inflamatoria intestinal en la población pediátrica. Piel 2018;33:21-32. [DOI: 10.1016/j.piel.2017.02.005] [Reference Citation Analysis]
18 Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: The relationship between intestinal bacteria and skin health. World J Dermatol 2017; 6(4): 52-58 [DOI: 10.5314/wjd.v6.i4.52] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
19 Chua-aguilera CJ, Möller B, Yawalkar N. Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clinic Rev Allerg Immunol 2017;53:371-93. [DOI: 10.1007/s12016-017-8632-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
20 Richter L, Rappersberger K. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis]. Hautarzt 2016;67:940-7. [PMID: 27830291 DOI: 10.1007/s00105-016-3894-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease. Radiographics. 2017;37:1135-1160. [PMID: 28548906 DOI: 10.1148/rg.2017160121] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
22 Joseph NE, Weber CR. Pathology of Inflammatory Bowel Disease. In: Baumgart DC, editor. Crohn's Disease and Ulcerative Colitis. Cham: Springer International Publishing; 2017. pp. 243-58. [DOI: 10.1007/978-3-319-33703-6_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Krati K, Ouarrach H, Pratic F, Oubaha S, Samlani Z. Les manifestations extradigestives au cours de la maladie de Crohn. J Afr Hepato Gastroenterol 2017;11:7-12. [DOI: 10.1007/s12157-016-0698-9] [Reference Citation Analysis]
24 Hagen JW, Swoger JM, Grandinetti LM. Cutaneous manifestations of crohn disease. Dermatol Clin. 2015;33:417-431. [PMID: 26143422 DOI: 10.1016/j.det.2015.03.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
25 Brown SR, Coviello LC. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease. Surg Clin North Am. 2015;95:1245-159, vii. [PMID: 26596925 DOI: 10.1016/j.suc.2015.08.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
26 Zampeli VA, Lippert U, Nikolakis G, Makrantonaki E, Tzellos TG, Krause U, Zouboulis CC. Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab. J Dermatol Case Rep 2015;9:62-6. [PMID: 26512301 DOI: 10.3315/jdcr.2015.1206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
27 Weisenseel P, Reich K. Psoriasis inversa. coloproctology 2016;38:115-9. [DOI: 10.1007/s00053-015-0046-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Weisenseel P, Reich K. Psoriasis inversa. Hautarzt 2015;66:408-12. [DOI: 10.1007/s00105-015-3628-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Ghazi LJ, Patil SA, Cross RK. Sexual dysfunction in inflammatory bowel disease. Inflamm Bowel Dis 2015;21:939-47. [PMID: 25504236 DOI: 10.1097/MIB.0000000000000260] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
30 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 115] [Cited by in F6Publishing: 123] [Article Influence: 14.4] [Reference Citation Analysis]
31 Shah NP, Goel RM, Escudier M. Treatment of a Crohn's disease-related cutaneous facial lesion with topical tacrolimus. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:e71-3. [PMID: 25151593 DOI: 10.1016/j.oooo.2014.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Byeon YM, Lee J, Lee SJ, Park CJ, Yun NR, Kim YD, Park CG, Kim MW. Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative Colitis. Intest Res 2014;12:153-6. [PMID: 25349583 DOI: 10.5217/ir.2014.12.2.153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Roux O, Bouhnik Y. Manifestaciones extradigestivas de las enfermedades inflamatorias intestinales crónicas. EMC - Tratado de Medicina 2014;18:1-6. [DOI: 10.1016/s1636-5410(14)66725-8] [Reference Citation Analysis]
34 Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero-Gómez M. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. J Gastroenterol Hepatol 2014;29:291-5. [PMID: 23927379 DOI: 10.1111/jgh.12352] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
35 Longman RS, Scherl EJ. Medical Management of Extraintestinal Manifestations of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_35] [Reference Citation Analysis]
36 Allanore Y, Ortonne N, Valeyrie-allanore L. Erythema Nodosum. Skin Manifestations in Rheumatic Disease 2014. [DOI: 10.1007/978-1-4614-7849-2_3] [Reference Citation Analysis]
37 Mazziotti S, Blandino A. Extraintestinal Complications. MR Enterography 2014. [DOI: 10.1007/978-88-470-5746-3_5] [Reference Citation Analysis]
38 Mazziotti S, Blandino A. Extraintestinal Complications. MR Enterography 2014. [DOI: 10.1007/978-88-470-5675-6_5] [Reference Citation Analysis]
39 Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: A review. World J Gastroenterol 2013; 19(46): 8571-8579 [PMID: 24379574 DOI: 10.3748/wjg.v19.i46.8571] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 130] [Article Influence: 11.4] [Reference Citation Analysis]
40 Krüger NA, Marchi JJD, Souza MMD. Biological Therapy for Pyoderma Gangrenosum. Journal of Coloproctology 2013;33:232-235. [DOI: 10.1016/j.jcol.2013.08.010] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Zippi M, Pica R, De Nitto D, Paoluzi P. Biological therapy for dermatological manifestations of inflammatory bowel disease. World J Clin Cases 2013; 1(2): 74-78 [PMID: 24303470 DOI: 10.12998/wjcc.v1.i2.74] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
42 Deregnaucourt D, Buche S, Coopman S, Basraoui D, Turck D, Delaporte E. Pyoderma gangrenosum avec localisations pulmonaires traité par infliximab. Annales de Dermatologie et de Vénéréologie 2013;140:363-6. [DOI: 10.1016/j.annder.2013.01.428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
43 Rice SA, Woo PN, El-Omar E, Keenan RA, Ormerod AD. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. BMC Res Notes 2013;6:19. [PMID: 23331739 DOI: 10.1186/1756-0500-6-19] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
44 Mazziotti S, Blandino A, Scribano E, Gaeta M, Mileto A, Fries W, Bombaci F, Ascenti G. MR enterography findings in abdominopelvic extraintestinal complications of Crohn's disease. J Magn Reson Imaging 2013;37:1055-63. [DOI: 10.1002/jmri.23859] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
45 Lázaro Saéz M, Hernández Martínez A, Bendezú García RÁ, Rodríguez Manrique MA, Simón López F, Medina Estévez E, Vega Sáenz JL. [Metastatic Crohn's disease. Response to adalimumab dose intensification]. Gastroenterol Hepatol 2012;35:321-5. [PMID: 22445940 DOI: 10.1016/j.gastrohep.2012.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
46 Allen CP, Burge SM. Extraintestinal Manifestations of Inflammatory Bowel Disease: Cutaneous and Oral Manifestations of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_49] [Reference Citation Analysis]
47 Joseph NE, Weber CR. Histology and Pathology of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Summaree AA, Al-saif F, Alkeraye S, Al-oraifej N. Crohn’s disease: Another unusual manifestation responded to metronidazole. Journal of the Saudi Society of Dermatology & Dermatologic Surgery 2011;15:67-69. [DOI: 10.1016/j.jssdds.2011.04.002] [Reference Citation Analysis]
49 Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: Do they influence treatment and outcome? World J Gastroenterol 2011; 17(22): 2702-2707 [PMID: 21734777 DOI: 10.3748/wjg.v17.i22.2702] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
50 Torres JADP, Santana RMD, Torres FADP, Moura AR, Torres Neto JDR. Doenças inflamatórias intestinais no Hospital Universitário da Universidade Federal de Sergipe: manifestações extraintestinais. Rev bras colo-proctol 2011;31:115-9. [DOI: 10.1590/s0101-98802011000200001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7:235-41. [PMID: 21857821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Amankwah Y, Haefner H. Vulvar edema. Dermatol Clin 2010;28:765-77. [PMID: 20883919 DOI: 10.1016/j.det.2010.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
53 Burns AM, Walsh N, Green PJ. Granulomatous vasculitis in Crohn's disease: a clinicopathologic correlate of two unusual cases. J Cutan Pathol 2010;37:1077-83. [PMID: 20456541 DOI: 10.1111/j.1600-0560.2010.01546.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
54 Nybaek H, Jemec G. Skin problems in stoma patients. Journal of the European Academy of Dermatology and Venereology 2010;24:249-57. [DOI: 10.1111/j.1468-3083.2010.03566.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
55 Alessandroni L, Scotti A. Cutaneous Manifestations. Crohn’s Disease 2010. [DOI: 10.1007/978-88-470-1472-5_19] [Reference Citation Analysis]
56 Navarro Tejedor R, Gallo Gutiérrez E. Lesiones elementales. Medicine - Programa de Formación Médica Continuada Acreditado 2010;10:3101-3106. [DOI: 10.1016/s0304-5412(10)70001-9] [Reference Citation Analysis]
57 Roth DE, Lazzerini M, Ronfani L. Commentary on ‘Oral Zinc for treating diarrhoea in children’, with a response from the review authors. Evid -Based Child Health 2009;4:1423-1427. [DOI: 10.1002/ebch.434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Kerr S, Kusmak JM, Stratman EJ. Dermatology for the general surgeon. Surg Clin North Am 2009;89:563-86. [PMID: 19465197 DOI: 10.1016/j.suc.2009.02.004] [Reference Citation Analysis]
59 Ullrich S, Schinke S, Both M, Knop KC, Kirkiles-smith NC, Gross WL, Lamprecht P. Refractory Central Nervous System Vasculitis and Gastrocnemius Myalgia Syndrome in Crohn's Disease Successfully Treated with Anti-Tumor Necrosis Factor-α Antibody. Seminars in Arthritis and Rheumatism 2009;38:337-47. [DOI: 10.1016/j.semarthrit.2008.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
60 Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2008;10:597-605. [PMID: 19006617 DOI: 10.1007/s11894-008-0108-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
61 Kerns MJJ, Mallatt BD, Shamma HN. Granulomatous Pigmented Purpura: An Unusual Histological Variant. The American Journal of Dermatopathology 2009;31:77-80. [DOI: 10.1097/dad.0b013e31817e23c9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
62 Timani S, Mutasim DF. Skin manifestations of inflammatory bowel disease. Clin Dermatol. 2008;26:265-273. [PMID: 18640523 DOI: 10.1016/j.clindermatol.2007.10.018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
63 Tsiamoulos Z, Karamanolis G, Polymeros D, Triantafyllou K, Oikonomopoulos T. Leukocytoclastic vasculitis as an onset symptom of Crohn's disease. Case Rep Gastroenterol 2008;2:410-4. [PMID: 21897791 DOI: 10.1159/000161562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
64 Quin A, Kane S, Ulitsky O. A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab. Nat Clin Pract Gastroenterol Hepatol. 2008;5:278-281. [PMID: 18364718 DOI: 10.1038/ncpgasthep1099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
65 Pozdnyakova O, Garg A, Mahalingam M. Nodular vasculitis - a novel cutaneous manifestation of autoimmune colitis. J Cutan Pathol 2008;35:315-9. [PMID: 18251747 DOI: 10.1111/j.1600-0560.2007.00797.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
66 Santiago Sánchez-mateos J, Martín Sáez E, Moreno Izquierdo R, González García C, Jaén Olasolo P. Fiebre, hematoquecia y úlceras cutáneas en un adulto joven. Revista Clínica Española 2008;208:102-104. [DOI: 10.1157/13115209] [Reference Citation Analysis]
67 Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1424-9. [PMID: 17567879 DOI: 10.1002/ibd.20196] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
68 Watson RE, Poddar R, Walker JM, McGuill I, Hoare LM, Griffiths CE, O’neill CA. Altered claudin expression is a feature of chronic plaque psoriasis. J Pathol. 2007;212:450-458. [PMID: 17582238 DOI: 10.1002/path.2200] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
69 Tan V, Bartlett M, Hosking P, Gibson PR. Annular purpura and ulcerative colitis: response to infliximab. Dig Liver Dis 2007;39:488-9. [PMID: 17383245 DOI: 10.1016/j.dld.2006.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Yang X, Yao W, Liu W, Li J, Lu Y. Clinical manifestations and outcomes in severe ulcerative colitis. Front Med China 2007;1:192-5. [PMID: 24557675 DOI: 10.1007/s11684-007-0036-0] [Reference Citation Analysis]
71 Sturniolo GC, Barollo M, D’incà R. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Disease and Familial Adenomatous Polyposis. [DOI: 10.1007/88-470-0434-9_7] [Reference Citation Analysis]
72 Barrie A, Plevy S. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. Gastroenterol Clin North Am 2006;35:883-93. [PMID: 17129819 DOI: 10.1016/j.gtc.2006.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
73 Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227-7236. [PMID: 16437620 DOI: 10.3748/wjg.v11.i46.7227] [Cited by in CrossRef: 222] [Cited by in F6Publishing: 238] [Article Influence: 13.1] [Reference Citation Analysis]
74 Sarzi-puttini P, Atzeni F, Carrabba M. Rheumatoid Arthritis and the Skin. Handbook of Systemic Autoimmune Diseases 2006. [DOI: 10.1016/s1571-5078(05)05013-0] [Reference Citation Analysis]
75 Savino A, Pelliccia P, Breda L, Verini M, Salladini C, Neri M, Angelucci D, Chiarelli F. Genital swelling in an adolescent patient. Eur J Pediatr 2006;165:76-9. [DOI: 10.1007/s00431-005-1713-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Travassos WJ, Cheifetz AS. Infliximab: Use in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2005;8:187-196. [PMID: 15913508 DOI: 10.1007/s11938-005-0011-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]